Brennan M. R

Nov 4, 2024 | rand.org | Brennan M. R |Aurash Naser-Tavakolian |Rebecca Gale |Michael Luu

BackgroundPhysician treatment preference may influence how risks are communicated in prostate cancer consultations. We identified persuasive language used when describing cancer prognosis, life expectancy, and side effects in relation to a physician's recommendation for aggressive (surgery/radiation) or nonaggressive (active surveillance/watchful waiting) treatment.